Viewing Study NCT01562158


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-02-21 @ 8:30 AM
Study NCT ID: NCT01562158
Status: COMPLETED
Last Update Posted: 2017-01-11
First Post: 2012-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module